"Real world" eligibility for aducanumab

被引：28
|
作者：
Canevelli, Marco [1 ,2 ]
Rossi, Paolo Dionigi [3 ]
Astrone, Paolo [4 ]
Consorti, Ernesto [5 ]
Vanacore, Nicola [2 ]
Cesari, Matteo [6 ,7 ]
机构：
[1] Sapienza Univ, Dept Human Neurosci, Viale Univ 30, I-00185 Rome, Italy
[2] Natl Inst Hlth, Natl Ctr Dis Prevent & Hlth Promot, Rome, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Geriatr Unit, Milan, Italy
[4] Azienda Socio Sanit Terr ASST Lodi, Subacute Care Unit, Lodi, Italy
[5] Univ Milan, Geriatr & Gerontol, Milan, Italy
[6] IRCCS Ist Clin Sci Maugeri, Geriatr Unit, Milan, Italy
[7] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2021年 / 69卷 / 10期
关键词：
D O I：
10.1111/jgs.17390
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：2995 / 2998
页数：4
相关论文
共 50 条
  • [41] Eligibility of a Real World Population for Phase 3 Clinical Trials for Chronic Hepatitis C Infection
    Angulo-Diaz, Veronica C.
    Sadigh, Katrin S.
    Ogbuagu, Onyema
    Sarkar, Souvik
    Villanueva, Merceditas
    Lim, Joseph K.
    GASTROENTEROLOGY, 2015, 148 (04) : S496 - S497
  • [42] Real-world eligibility and cost-effectiveness analysis for empagliflozin in patients with heart failure
    Kim, E. S.
    Park, S. K.
    Youn, J. C.
    EUROPEAN HEART JOURNAL, 2022, 43 : 972 - 972
  • [43] Editorial: Real World Transcatheter Edge to Edge Repair Eligibility in HF Patients: Finding the Opportunity
    Asgar, Anita W.
    Panagiotidis, Theofilos
    STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM, 2024, 8 (02):
  • [44] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, Luca
    Ferrari, Ilaria
    Gaudio, Carlo
    Cicogna, Francesco
    Tota, Claudia
    Petronilli, Valentina
    Mennuni, Silvia
    Ruvo, Ermenegildo De
    Calo, Leonardo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [45] Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea
    Kim, Eui-Soon
    Park, Sun-Kyeong
    Youn, Jong-Chan
    Lee, Hye Sun
    Lee, Hae-Young
    Cho, Hyun-Jai
    Choi, Jin-Oh
    Jeon, Eun-Seok
    Lee, Sang Eun
    Kim, Min-Seok
    Kim, Jae-Joong
    Hwang, Kyung-Kuk
    Cho, Myeong-Chan
    Chae, Shung Chull
    Kang, Seok-Min
    Park, Jin Joo
    Choi, Dong-Ju
    Yoo, Byung-Su
    Cho, Jae Yeong
    Kim, Kye Hun
    Oh, Byung-Hee
    Greenberg, Barry
    Baek, Sang Hong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (01)
  • [46] Real-World Eligibility and Cost-Effectiveness Analysis for Empagliflozin in Patients with Heart Failure
    Kim, E.
    Kim, K.
    Park, S.
    Youn, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S82 - S82
  • [47] Improving Diversity in Clinical Trials by Using Real-world Data to Define Eligibility Criteria
    Royce, Trevor J.
    Zhao, Yihua
    Ryals, Cleo A.
    JAMA ONCOLOGY, 2023, 9 (04) : 455 - 456
  • [48] Real-world Eligibility for Revascularization in Acute Stroke: A 12 Year Single Center Statistics
    Vanacker, Peter
    Lambrou, Dimitris
    Eskandari, Ashraf
    Michel, Patrik
    STROKE, 2016, 47
  • [49] HOW MANY PATIENTS IN A REAL WORLD GLIOBLASTOMA POPULATION MEET ELIGIBILITY CRITERIA IN CLINICAL TRIALS?
    Skaga, Erlend
    Skretteberg, Marthe Andrea
    Johannesen, Tom Borge
    Brandal, Petter
    Vik-Mo, Einar Osland
    Helseth, Eirik
    Langmoen, Iver Arne
    NEURO-ONCOLOGY, 2019, 21 : 80 - 80
  • [50] The eligibility question - the real source of depersonalisation?
    Slasberg, Colin
    Beresford, Peter
    DISABILITY & SOCIETY, 2016, 31 (07) : 969 - 973
12345